Literature DB >> 32262971

Partially PEGylated dendrimer-entrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery.

Wenxiu Hou1, Ping Wei, Lingdan Kong, Rui Guo, Shige Wang, Xiangyang Shi.   

Abstract

Exploring a plasmid DNA (pDNA)/small interfering RNA (siRNA) delivery vector with excellent biocompatibility and high gene transfection efficiency still remains a great challenge. In this research, generation 5 (G5) dendrimer-entrapped gold nanoparticles (Au DENPs) partially modified with polyethylene glycol monomethyl ether (mPEG) were designed as non-viral pDNA/siRNA delivery vectors. The pDNA that can encode luciferase (Luc) or enhanced green fluorescent protein (EGFP) and the Bcl-2 siRNA that can knockdown the expression of the Bcl-2 protein were successfully packaged by the partially PEGylated Au DENPs and effectively delivered into HeLa cells. The length of the surface conjugated mPEG chains and the composition of the entrapped Au NPs were systematically altered to explore their influences on the structure, cytotoxicity, and pDNA or siRNA delivery efficiency. We show that the modified mPEG and entrapped Au NPs can significantly improve the encoding of Luc and EGFP or silence the Bcl-2 protein expression, and the {(Au0)50-G5.NH2-mPEG2K} DENPs display the best DNA or siRNA delivery efficiency among all the designed partially PEGylated Au DENPs. The Luc transfection efficiency of the {(Au0)50-G5.NH2-mPEG2K} was about 292 times higher than that of the G5.NH2 dendrimers at an N/P ratio of 5 : 1, and the Bcl-2 protein was silenced to 15% using the {(Au0)50-G5.NH2-mPEG2K} as a vector relative to the expression level transfected using the G5.NH2 dendrimers (100%). With enhanced pDNA/siRNA transfection efficiency and less cytotoxicity, the PEGylated Au DENPs may hold great promise to be used in pDNA and siRNA delivery applications.

Entities:  

Year:  2016        PMID: 32262971     DOI: 10.1039/c6tb00710d

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  7 in total

1.  Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data.

Authors:  Begoña Alburquerque-González; María Dolores López-Abellán; Ginés Luengo-Gil; Silvia Montoro-García; Pablo Conesa-Zamora
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Applications and Limitations of Dendrimers in Biomedicine.

Authors:  Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

3.  Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Authors:  Yelixza I Avila; Morgan Chandler; Edward Cedrone; Hannah S Newton; Melina Richardson; Jie Xu; Jeffrey D Clogston; Neill J Liptrott; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

4.  Effective CpG Delivery Using Zwitterion-Functionalized Dendrimer-Entrapped Gold Nanoparticles to Promote T Cell-Mediated Immunotherapy of Cancer Cells.

Authors:  Huan Chen; Yiming Zhang; Lulu Li; Rui Guo; Xiangyang Shi; Xueyan Cao
Journal:  Biosensors (Basel)       Date:  2022-01-27

5.  β-Cyclodextrin and Oligoarginine Peptide-Based Dendrimer-Entrapped Gold Nanoparticles for Improving Drug Delivery to the Inner Ear.

Authors:  Jia Luo; XueXin Lin; LiLing Li; JingQian Tan; Peng Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11

Review 6.  Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics.

Authors:  Serge Mignani; Xiangyang Shi; Maria Bryszewska; Dzmitry Shcharbin; Jean-Pierre Majoral
Journal:  Explor Target Antitumor Ther       Date:  2022-02-25

Review 7.  Gold-Polymer Nanocomposites for Future Therapeutic and Tissue Engineering Applications.

Authors:  Panangattukara Prabhakaran Praveen Kumar; Dong-Kwon Lim
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.